10 – 11 May 2018 | New York, NY

  • Lady Liberty



  • City Skyline
  • myCME
10 – 11 May 2018 | Sheraton New York Times Square

16th Annual CME Symposium

This advanced CME activity will provide participants with state-of-the-art information and practical guidance on progress in managing HIV, hepatitis B, and hepatitis C, including drug development and treatment, management of important comorbidities and drug-drug interactions, enabling practitioners to deliver the highest quality care in all practice settings.

The primary goals of this activity are to increase each participant’s competence to:

  • Summarize current approaches to achieving a cure for HIV infection
  • Identify the optimal antiretroviral management options for
    patients with HIV and newer therapies in development
  • Illustrate advances in the approach to prevention of HIV infection
  • Recognize factors important for assessing risk for cardiovascular disease and
    options for preventing cardiovascular morbidities
  • Demonstrate the opportunities and challenges of treating addicted patients
  • Detail the current treatment options for  management of patients with
    HBV or HCV and newer therapies now in development
  • Explain how to recognize, avoid and manage drug-drug interactions
  • Describe developments and controversies in HCV-infected organ transplantation

Target Audience

The curriculum offered at this activity is designed to meet the needs of Infectious Disease Physicians, Hepatologists, Gastroenterologists, Family Physicians, Nurse Practitioners, Physician Assistants, Nurses, Pharmacists, and others involved in frontline HIV and Hepatitis patient care and treatment.

This CME activity is made possible, in part, by educational grants provided or pledged by:

 Gilead Sciences
 ViiV Healthcare
 AbbVie, Merck